APA (7th ed.) Citation

Taeil Kim, Dong Eon Kim, Eun Mi Jo, Yeji Lee, Da Woon Kim, Hyo Jin Kim, . . . Harin Rhee. (2024). The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: A retrospective study on patient outcomes and safety. The Korean Society of Nephrology.

Chicago Style (17th ed.) Citation

Taeil Kim, Dong Eon Kim, Eun Mi Jo, Yeji Lee, Da Woon Kim, Hyo Jin Kim, Eun Young Seong, Sang Heon Song, and Harin Rhee. The Role of Nafamostat Mesylate Anticoagulation in Continuous Kidney Replacement Therapy for Critically Ill Patients with Bleeding Tendencies: A Retrospective Study on Patient Outcomes and Safety. The Korean Society of Nephrology, 2024.

MLA (9th ed.) Citation

Taeil Kim, et al. The Role of Nafamostat Mesylate Anticoagulation in Continuous Kidney Replacement Therapy for Critically Ill Patients with Bleeding Tendencies: A Retrospective Study on Patient Outcomes and Safety. The Korean Society of Nephrology, 2024.